Circulating magnesium & Acute phage inflammatory reactant in North Indian adult population

Geeta Shamnani, Vani Gupta, Charushilla Atul Rukadikar, Shraddha Singh, Sunita Tiwari, Shekhawat Singh Bhartiy

Abstract


Background: The increase of several serum proteins named acute phase reactants is a feature of the tissue response to inflammation. C-reactive protein (CRP) is one of the most sensitive acute-phase reactants in humans. Magnesium is found to be associated with these inflammatory reactants in previous studies.

Objectives: The aim of this study was to investigate the relationship between serum magnesium levels and C- reactive protein in apparently healthy adults.

Methods and material: This is a population based cross-sectional study. Total 130 adults of age between 25-65 years, were recruited with prior ethical approval and with written informed consent.  

Result: Mean value of serum magnesium was found to be 2.01mg/dl (±0.29) with range between 1.4mg/dl to 2.9mg/dl. Not a single case of severe hypomagnesemia (< 1.2 mg/dl) was found. Serum magnesium was found to have no significant correlation with C-reactive protein (r = -0.12, p=0.23).

Conclusion: Authors report no significant co-relation between serum magnesium and CRP. Further larger studies are required to be done.


Keywords


Circulating magnesium, acute phase inflammatory reactants, cross-sectional study, hypomagnesemia, C-reactive protein, North Indian adult population

Full Text:

PDF

References


Chacko SA, Song Y, Nathan L, Tinker L, de Boer IH, Tylavsky F. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 2010;33:304–10.

Song Y, Li TY, van Dam RM, Manson JE, Hu FB. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 2007;85:1068–74.

Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005;28:1438–44.

He K, Liu K, Daviglus ML, Morris SJ, Loria CM, VanHorn L. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006;113:1675–82.

Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med 2007;167:956–65.

Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs DR Jr. Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 2010;33:2604–10.

Elwood PC, Fehily AM, Ising H, Poor DJ, Pickering J, Kamel F. Dietary magnesium does not predict ischaemic heart disease in the Caerphilly cohort. Eur J Clin Nutr 1996;50:694–7.

Song Y, Manson JE, Cook NR, Albert CM, Buring JE, Liu S. Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol 2005;96:1135–41.

Al-Delaimy WK, Rimm EB,Willett WC, Stampfer MJ, Hu FB. Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr 2004;23:63–70.

Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC)Study. Am Heart J 1998;136:480–90.

Ford ES. Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int J Epidemiol 1999;28:645–51.

Abbott RD, Ando F, Masaki KH, Tung KH, Rodriguez BL, Petrovitch H. Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol 2003;92:665–9.

Mejía¬ Rodríguez F., Shamah¬Levy T., Villalpando S., García¬Guerra A., MéndezGómez Humarán I.: Iron, zinc, copper and magnesium deficiencies in Mexican adults from the National Health and Nutrition Survey 2006. Salud Publica Mex 2013; 55: 275¬-284.

Volpe SL. Magnesium in Disease Prevention and Overall Health. Adv Nutr 2013; 4: 378S-383S.

Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnes Res 2010; 23: S194-S198.

Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium status in the United States: Are the health consequences underestimated? Nutr Rev 2012; 70: 153-164.

Sarafian DA, Berman S, Mor A, Shteinshnaider M, Gorelik O, Tzur I, Alon I, Modai D, Cohen N. Magnesium and C-¬reactive protein in heart failure: An anti¬inflammatory effect of magnesium administration? ¬ Eur J Nutr ¬ 2007; 46 (4):230¬-7.

Švagždienė M, Širvinskas E, Baranauskienė D, Adukauskienė D. Correlation of magnesium deficiency with C-reactive protein in elective cardiac surgery with cardiopulmonary bypass for ischemic heart disease. Medicina (Kaunas) 2015; 51 (2): 100-6.

Cojocaru IM, Cojocaru M, Tănăsescu R, Iacob SA, Iliescu I. Changes of magnesium serum levels in patients with acute ischemic stroke and acute infections. Rom J Intern Med ¬ 2009; 47 (2): 169-¬71.

Luis E. Mendíaa S, Morána MR, Romeroa FG. C-reactive protein levels in Subjects with Prediabetes and Hypomagnesemia: A Clinical Randomized Double-blind Placebo-controlled Trial. Archives of Medical Research 2014; 45(4): 325–330.

Niehoff AG, Van Haeften TW, Onland¬Moret NC, Elbers CC, Wijmenga C, VanderSchouw YT. C -reactive protein is independently associated with glucose but not with insulin resistance in healthy men. Diabetes Care 2007; 30: 1627-¬1629.




DOI: https://doi.org/10.7439/ijbar.v9i4.4762



Copyright (c) 2018 International Journal of Biomedical and Advance Research

Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.